Related Experiment Videos
[Renal tumor embolization].
H J Hansmann1, P Hallscheidt, K Aretz
1Abteilung Radiodiagnostik, Universitätsklinik Heidelberg.
Der Radiologe
|October 20, 1999
Summary
Renal tumor embolization is a valuable technique for reducing blood loss and simplifying surgery in advanced renal cell carcinomas. However, for inoperable patients, palliative embolization offers symptom relief but has a limited median survival of 3.5 months.
Area of Science:
- Interventional Radiology
- Oncology
- Nephrology
Context:
- Advancements in renal carcinoma diagnosis and surgical techniques have altered patient selection for embolization.
- Preoperative embolization is now standard for advanced renal cell carcinomas, including those with vena cava tumor thrombus or T4 stage.
Purpose:
- To evaluate the role and outcomes of renal tumor embolization in both preoperative and palliative settings.
- To assess the impact of embolization on intraoperative blood loss, surgical preparation, and symptom management.
Summary:
- Renal tumor embolization effectively reduces intraoperative blood loss and simplifies surgical preparation in advanced renal cell carcinomas.
- Palliative embolization using Ethibloc can successfully manage hemorrhage and pain in inoperable patients, achieving local tumor control and ablation.
- Despite local control, palliative embolization in inoperable patients yields a median survival of only 3.5 months.
Impact:
- Embolization enhances surgical outcomes for advanced renal cell carcinomas by minimizing blood loss and facilitating procedures.
- Palliative embolization provides crucial symptom management for inoperable patients, though survival remains limited.
- The findings necessitate careful consideration of life expectancy versus symptom relief when selecting inoperable patients for palliative embolization.